|
US3472859A
(en)
|
1966-11-01 |
1969-10-14 |
Sterling Drug Inc |
1-alkyl-1,4-dihydro-4-oxo-3 quinoline-carboxylic acids and esters
|
|
JPS4826772Y1
(enExample)
|
1969-04-04 |
1973-08-06 |
|
|
|
ATE27451T1
(de)
|
1981-03-24 |
1987-06-15 |
Ciba Geigy Ag |
Acyl-chinolinonderivate, verfahren zu ihrer herstellung, diese enthaltende pharmazeutische praeparate und ihre verwendung.
|
|
US4656283A
(en)
|
1982-05-25 |
1987-04-07 |
American Cyanamid Company |
Alkyl esters of substituted 2-methyl-3-quinolinecarboxylic acid and quinoline-2,3-dicarboxylic acid
|
|
US4910327A
(en)
|
1982-05-25 |
1990-03-20 |
American Cyanamid Company |
Alkyl esters of substituted 2-methyl-3-quinolinecarboxylic acid and quinoline-2,3-dicarboxylic acid: dialkyl 3-(substituted)phenylaminobut-2-ene-dioates and methods for the preparation thereof
|
|
PT79699B
(en)
|
1983-12-22 |
1986-12-10 |
Pfizer |
Process for preparing quinolone inotropic agents
|
|
FR2634483B2
(fr)
|
1987-12-29 |
1994-03-04 |
Esteve Labor Dr |
Derives des acides 7-(1-azetidinyl)-1,4-dihydro-4-oxoquinoleine-3-carboxyliques, leur preparation et leur application en tant que medicaments
|
|
CA2002864C
(en)
|
1988-11-29 |
1999-11-16 |
Eddy J. E. Freyne |
(1h-azol-1-ylmethyl) substituted quinoline, quinazoline or quinoxaline derivatives
|
|
CA2102780C
(en)
|
1991-05-10 |
2007-01-09 |
Alfred P. Spada |
Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase
|
|
US5478832A
(en)
|
1992-05-08 |
1995-12-26 |
The Green Cross Corporation |
Quinoline compounds
|
|
JPH0826772A
(ja)
|
1994-07-22 |
1996-01-30 |
Sony Corp |
融着用ガラス、その製造方法及び製造装置、並びに磁気ヘッドの製造方法
|
|
EP0709377B1
(en)
|
1994-10-27 |
1999-09-29 |
Asahi Glass Company Ltd. |
Process for producing quinolin-2-yl benzoic acid compounds
|
|
GB9523267D0
(en)
|
1995-11-14 |
1996-01-17 |
Sandoz Ltd |
Organic compounds
|
|
TR199800825T2
(xx)
|
1995-12-08 |
1998-08-21 |
Janssen Pharmaceutica N.V. |
Farnesil protein transferini inhibe eden (imidazol-5-il) metil-2-kinolinon t�revleri.
|
|
US6150352A
(en)
|
1996-05-20 |
2000-11-21 |
Merck & Co., Inc. |
Antagonists of gonadotropin releasing hormone
|
|
RU2209066C2
(ru)
*
|
1997-06-02 |
2003-07-27 |
Янссен Фармацевтика Н.В. |
Производные (имидазол-5-ил)метил-2-хинолинона в качестве ингибиторов пролиферации клеток гладкой мышцы
|
|
HUP0101999A3
(en)
|
1997-12-22 |
2003-06-30 |
Upjohn Co |
4-hydroxyquinoline-3-carboxamides and hydrazides use of them and pharmaceutical compositions containing them
|
|
FR2776388B1
(fr)
|
1998-03-20 |
2006-04-28 |
Lipha |
Utilisation de recepteurs de la famille ror pour le criblage de substances utiles pour le traitement de l'atherosclerose
|
|
US6399629B1
(en)
|
1998-06-01 |
2002-06-04 |
Microcide Pharmaceuticals, Inc. |
Efflux pump inhibitors
|
|
PL193464B1
(pl)
|
1998-07-06 |
2007-02-28 |
Janssen Pharmaceutica Nv |
Zastosowanie inhibitora białkowej transferazy farnezylowej
|
|
HRP20000904A2
(en)
*
|
1998-07-06 |
2001-12-31 |
Janssen Pharmaceutica Nv |
Farnesyl protein transferase inhibitors for treating arthropathies
|
|
JP2000169451A
(ja)
|
1998-09-30 |
2000-06-20 |
Kyorin Pharmaceut Co Ltd |
６，７―ジ置換キノリンカルボン酸誘導体とその付加塩及びそれらの製造方法
|
|
US6458800B1
(en)
|
1998-12-23 |
2002-10-01 |
Janssen Pharmaceutica N.V. |
1,2-annelated quinoline derivatives
|
|
US6248736B1
(en)
|
1999-01-08 |
2001-06-19 |
Pharmacia & Upjohn Company |
4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents
|
|
US6248739B1
(en)
|
1999-01-08 |
2001-06-19 |
Pharmacia & Upjohn Company |
Quinolinecarboxamides as antiviral agents
|
|
CZ20012910A3
(cs)
|
1999-02-11 |
2002-02-13 |
Pfizer Products Inc. |
Heteroarylem-substituované chinolin-2-onové deriváty pouľitelné jako protinádorové prostředky
|
|
DK1106612T3
(da)
|
1999-11-30 |
2004-05-17 |
Pfizer Prod Inc |
Quinolinderivater, der er nyttige til inhibering af farnesylproteintransferase
|
|
DE60118889T2
(de)
|
2000-02-04 |
2006-11-30 |
Janssen Pharmaceutica N.V. |
Farnesyl protein transferase inhibitoren zur behandlung von brustkrebs
|
|
EP1267848B1
(en)
|
2000-02-24 |
2007-10-17 |
Janssen Pharmaceutica N.V. |
Dosing regimen comprising a farnesyl protein transferase inhibitor for the treatment of cancer
|
|
AU2001256166A1
(en)
|
2000-02-29 |
2001-09-12 |
Janssen Pharmaceutica N.V. |
Farnesyl protein transferase inhibitor combinations with anti-tumor nucleoside derivatives
|
|
AU2001240658A1
(en)
|
2000-02-29 |
2001-09-12 |
Janssen Pharmaceutica N.V. |
Farnesyl protein transferase inhibitor combinations with camptothecin compounds
|
|
WO2001064246A2
(en)
|
2000-02-29 |
2001-09-07 |
Janssen Pharmaceutica N.V. |
Farnesyl protein transferase inhibitor combinations with an her2 antibody
|
|
CA2397694A1
(en)
|
2000-02-29 |
2001-09-07 |
Janssen Pharmaceutica Inc. |
Farnesyl protein transferase inhibitor combinations
|
|
AU2001244166A1
(en)
|
2000-02-29 |
2001-09-12 |
Janssen Pharmaceutica N.V. |
Farnesyl protein transferase inhibitor combinations with further anti-cancer agents
|
|
EP1261348A2
(en)
|
2000-02-29 |
2002-12-04 |
Janssen Pharmaceutica N.V. |
Combinations of a farnesyl protein transferase inhibitor with nitrogen mustard or nitrosourea alkylating agents
|
|
AU2001246478A1
(en)
|
2000-02-29 |
2001-09-12 |
Janssen Pharmaceutica N.V. |
Farnesyl protein transferase inhibitor combinations with taxane compounds
|
|
JP2003525246A
(ja)
|
2000-02-29 |
2003-08-26 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
白金化合物とのファルネシルタンパク質トランスフェラーゼ阻害剤の組み合わせ剤
|
|
CA2397253A1
(en)
|
2000-02-29 |
2001-09-07 |
Janssen Pharmaceutica N.V. |
Farnesyl protein transferase inhibitor combinations with anti-tumor anthracycline derivatives
|
|
WO2001064196A2
(en)
|
2000-02-29 |
2001-09-07 |
Janssen Pharmaceutica N.V. |
Farnesyl protein transferase inhibitor combinations with vinca alkaloids
|
|
JP2003525238A
(ja)
|
2000-02-29 |
2003-08-26 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
抗腫瘍性ポドフィロトキシン誘導体とのファルネシルタンパク質トランスフェラーゼ阻害剤組み合わせ剤
|
|
US6844357B2
(en)
|
2000-05-01 |
2005-01-18 |
Pfizer Inc. |
Substituted quinolin-2-one derivatives useful as antiproliferative agents
|
|
US6525049B2
(en)
|
2000-07-05 |
2003-02-25 |
Pharmacia & Upjohn Company |
Pyrroloquinolones as antiviral agents
|
|
US6624159B2
(en)
|
2000-07-12 |
2003-09-23 |
Pharmacia & Upjohn Company |
Heterocycle carboxamides as antiviral agents
|
|
PT1299395E
(pt)
|
2000-07-12 |
2005-01-31 |
Upjohn Co |
Oxazinoquinolonas uteis para o tratamento de infeccoes provocadas por virus
|
|
ATE321038T1
(de)
|
2000-09-25 |
2006-04-15 |
Janssen Pharmaceutica Nv |
Chinolin- und chinazolinderivate und deren verwendung als farnesyl transferase inhibitoren
|
|
ES2313991T3
(es)
|
2000-09-25 |
2009-03-16 |
Janssen Pharmaceutica Nv |
Derivados de 6-heterociclilmetil-quinolina y quinazolina que inhiben la farnesil transferasa.
|
|
WO2002024687A1
(en)
|
2000-09-25 |
2002-03-28 |
Janssen Pharmaceutica N.V. |
Farnesyl transferase inhibiting 6-heterocyclylmethyl quinolinone derivatives
|
|
AU2001293847B2
(en)
|
2000-10-02 |
2007-05-24 |
Janssen Pharmaceutica N.V. |
Metabotropic glutamate receptor antagonists
|
|
WO2002043733A1
(en)
|
2000-11-28 |
2002-06-06 |
Janssen Pharmaceutica N.V. |
Farnesyl protein transferase inhibitors for the treatment of inflammatory bowel disease
|
|
WO2002051835A1
(en)
|
2000-12-27 |
2002-07-04 |
Janssen Pharmaceutica N.V. |
Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives
|
|
JP4969016B2
(ja)
|
2001-02-15 |
2012-07-04 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
抗エストロゲン剤とファルネシルプロテイントランスフェラーゼ阻害剤の組み合わせ物
|
|
CA2433467A1
(en)
|
2001-03-01 |
2002-09-12 |
Joseph W. Strohbach |
Substituted quinolinecarboxamides as antiviral agents
|
|
EP1390033A1
(en)
|
2001-04-25 |
2004-02-25 |
Janssen Pharmaceutica N.V. |
Farnesyl protein transferase inhibitors for treating cachexia
|
|
WO2003000705A1
(en)
|
2001-06-21 |
2003-01-03 |
Ariad Pharmaceuticals, Inc. |
Novel quinolines and uses thereof
|
|
EP1458719A1
(en)
|
2001-12-20 |
2004-09-22 |
PHARMACIA & UPJOHN COMPANY |
Pyridoquinoxaline antivirals
|
|
JP2005516957A
(ja)
|
2001-12-20 |
2005-06-09 |
ファルマシア アンド アップジョン カンパニー リミティド ライアビリティー カンパニー |
ピリドキノキサリン抗ウイルス剤
|
|
MXPA04009435A
(es)
|
2002-03-29 |
2005-01-25 |
Janssen Pharmaceutica Nv |
Derivados de quinolina y quinolinona radiomarcados y su uso como ligandos de receptor de glutamato metabotropico.
|
|
EP2045242A1
(en)
|
2002-08-13 |
2009-04-08 |
Shionogi&Co., Ltd. |
Heterocyclic compounds having inhibitory activity against HIV integrase
|
|
WO2004019932A1
(en)
|
2002-08-30 |
2004-03-11 |
Pharmacia & Upjohn Company |
Method of preventing or treating atherosclerosis or restenosis
|
|
GB0222516D0
(en)
|
2002-09-27 |
2002-11-06 |
Karobio Ab |
Novel compounds
|
|
RS20060018A
(sr)
|
2003-07-14 |
2007-12-31 |
Arena Pharmaceuticals Inc., |
Derivati spojenih arila i heteroarila kao modulatori metabolizma u profilaksi i lečenju sa njima povezanih stanja
|
|
EA009875B1
(ru)
|
2003-11-20 |
2008-04-28 |
Янссен Фармацевтика Н.В. |
6-алкенил и 6-фенилалкил замещенные 2-хинолиноны и 2-хиноксалиноны в качестве ингибиторов поли(адф-рибоза) полимеразы
|
|
AU2004295059B2
(en)
|
2003-12-05 |
2010-12-16 |
Janssen Pharmaceutica N.V. |
6-substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors
|
|
EA010592B1
(ru)
|
2003-12-10 |
2008-10-30 |
Янссен Фармацевтика Н.В. |
6-замещённые циклогексилалкил 2-замещённые хинолиноны и 2-хиноксалиноны в качестве ингибиторов поли(adp-рибоза)полимеразы
|
|
WO2005058834A2
(en)
|
2003-12-12 |
2005-06-30 |
Wyeth |
Quinolines useful in treating cardiovascular disease
|
|
CN1909907B
(zh)
|
2004-01-23 |
2010-06-23 |
詹森药业有限公司 |
喹啉衍生物及其在制备分枝杆菌抑制剂中的用途
|
|
BRPI0507312A
(pt)
|
2004-01-29 |
2007-06-26 |
Janssen Pharmaceutica Nv |
derivados de quinolina para uso como inibidores micobacterianos
|
|
JP2005225250A
(ja)
|
2004-02-10 |
2005-08-25 |
Murakami Corp |
車載用監視装置
|
|
JP4969443B2
(ja)
|
2004-06-30 |
2012-07-04 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
Ｐａｒｐ阻害剤としてのキナゾリノン誘導体
|
|
CA2574095C
(en)
|
2004-08-04 |
2013-05-21 |
Meiji Seika Kaisha, Ltd. |
Quinoline derivatives and insecticide comprising thereof as active ingredient
|
|
KR100686531B1
(ko)
|
2004-08-31 |
2007-02-23 |
한국화학연구원 |
히스톤 디아세틸라제 저해활성을 갖는 아릴아미노메틸프로페닐 벤즈하이드록시아마이드 유도체 및 그의 제조방법
|
|
ME01509B
(me)
|
2004-11-05 |
2014-04-20 |
Janssen Pharmaceutica Nv |
Terapeutska upotreba inhibitora farneziltransferaze i postupci praćenja njihove efikasnosti
|
|
JO2855B1
(en)
|
2005-08-03 |
2015-03-15 |
شركة جانسين فارماسوتيكا ان. في |
Quinoline derivatives acting as antibacterial agents
|
|
JO2952B1
(en)
|
2005-08-03 |
2016-03-15 |
جانسين فارماسوتيكا ان. في |
Quinoline derivatives acting as antibacterial agents
|
|
WO2007088978A1
(ja)
|
2006-02-03 |
2007-08-09 |
Meiji Seika Kaisha, Ltd. |
新規キノリン誘導体およびこれを有効成分として含有する農園芸用殺菌剤
|
|
US8389739B1
(en)
|
2006-10-05 |
2013-03-05 |
Orphagen Pharmaceuticals |
Modulators of retinoid-related orphan receptor gamma
|
|
KR101083177B1
(ko)
|
2006-10-23 |
2011-11-11 |
에스지엑스 파마슈티컬스, 인코포레이티드 |
트리아졸로-피리다진 단백질 키나제 조정제
|
|
JO3271B1
(ar)
|
2006-12-06 |
2018-09-16 |
Janssen Pharmaceutica Nv |
مشتقات الكوينولين المضادة للجراثيم
|
|
AR065093A1
(es)
|
2007-02-05 |
2009-05-13 |
Merck Frosst Canada Ltd |
Compuestos farmacéuticos inhibidores de la biosintesis de leucotrienos
|
|
UY30892A1
(es)
|
2007-02-07 |
2008-09-02 |
Smithkline Beckman Corp |
Inhibidores de la actividad akt
|
|
EP2155197A4
(en)
|
2007-03-09 |
2011-10-12 |
Link Medicine Corp |
TREATMENT OF LYSOSOMAL STORAGE DISEASES
|
|
CA2688823A1
(en)
|
2007-05-21 |
2008-11-27 |
Sgx Pharmaceuticals, Inc. |
Heterocyclic kinase modulators
|
|
CN101143845B
(zh)
|
2007-10-15 |
2010-08-25 |
中国药科大学 |
取代喹啉甲酰胍衍生物、其制备方法及其医药用途
|
|
CA2712256A1
(en)
|
2008-01-18 |
2009-07-23 |
Allergan, Inc. |
Substitued-aryl-(imidazole)-methyl)-phenyl compounds as subtype selective modulators of alpha 2b and/or alpha 2c adrenergic receptors
|
|
JP2011511056A
(ja)
|
2008-02-05 |
2011-04-07 |
ファイザー・インク |
Ｃｎｓ障害および代謝障害治療のためのピリジニルアミド
|
|
WO2009140138A1
(en)
|
2008-05-13 |
2009-11-19 |
Allergan, Inc. |
Quinolynylmethylimidizoles as therapeutic agents
|
|
WO2010068296A1
(en)
|
2008-12-11 |
2010-06-17 |
Stiefel Laboratories, Inc. |
Piperazine carboxamidines as antimicrobial agents
|
|
WO2010127208A1
(en)
|
2009-04-30 |
2010-11-04 |
Forest Laboratories Holdings Limited |
Inhibitors of acetyl-coa carboxylase
|
|
CN101899011B
(zh)
|
2009-05-26 |
2013-01-16 |
北京大学 |
氨基二硫代甲酸酯类化合物、其制备方法和应用
|
|
TWI428332B
(zh)
|
2009-06-09 |
2014-03-01 |
Hoffmann La Roche |
雜環抗病毒化合物
|
|
CA2781865A1
(en)
|
2009-06-25 |
2010-12-29 |
Amgen Inc. |
Polycyclic derivatives of pyridine and their use in the treatment of (inter alia) rheumatoid arthritis and similar diseases
|
|
BR112012008061A2
(pt)
|
2009-08-20 |
2016-03-01 |
Novartis Ag |
compostos de oxima heterocíclica
|
|
EP2368886A1
(en)
|
2010-03-01 |
2011-09-28 |
Phenex Pharmaceuticals AG |
Novel compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (ROR gamma, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune desease
|
|
US9101600B2
(en)
|
2010-03-11 |
2015-08-11 |
New York University |
Compounds as RORγt modulators and uses thereof
|
|
CN103025313A
(zh)
|
2010-04-15 |
2013-04-03 |
卓莫赛尔公司 |
用于减小或消除苦味的化合物、组合物和方法
|
|
JP6063870B2
(ja)
|
2010-11-08 |
2017-01-18 |
ライセラ・コーポレイション |
ＲＯＲγ活性の阻害用のＮ−スルホニル化テトラヒドロキノリンおよび関連二環化合物および病気の治療
|
|
WO2012116137A2
(en)
|
2011-02-24 |
2012-08-30 |
Emory University |
Jab1 blocking compositions for ossification and methods related thereto
|
|
KR101964478B1
(ko)
|
2011-04-28 |
2019-04-01 |
니뽄 다바코 산교 가부시키가이샤 |
아미드 화합물 및 그의 의약 용도
|
|
US9586928B2
(en)
|
2011-05-16 |
2017-03-07 |
The Scripps Research Institute |
Modulators of the nuclear hormone receptor ROR
|
|
GB201118652D0
(en)
|
2011-10-28 |
2011-12-07 |
Astex Therapeutics Ltd |
New compounds
|
|
WO2013064231A1
(en)
|
2011-10-31 |
2013-05-10 |
Phenex Pharmaceuticals Ag |
SEVEN-MEMBERED SULFONAMIDES AS MODULATORS OF RAR-RELATED ORPHAN RECEPTOR-GAMMA (RORγ, NR1F3)
|
|
EP2800745B1
(en)
|
2011-12-02 |
2020-02-12 |
Phenex Pharmaceuticals AG |
Pyrrolo carboxamides as modulators of orphan nuclear receptor rar-related orphan receptor-gamma (rory, nr1f3) activity and for the treatment of chronic inflammatory and autoimmune diseases
|